These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21572447)

  • 1. In vitro comparison of the vaporesection of human benign prostatic hyperplasia using 70- and 120-W 2-µm lasers.
    Luo GH; Xia SJ; Sun ZL
    Asian J Androl; 2011 Jul; 13(4):636-9. PubMed ID: 21572447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro studies of 2 µm laser treatment of benign prostatic hyperplasia].
    Luo GH; Yang XS; Liu J; Sun ZL; Xia SJ
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(30):2351-4. PubMed ID: 24300200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow-up.
    Fu WJ; Hong BF; Yang Y; Zhang X; Gao JP; Zhang L; Wang XX
    BJU Int; 2009 Feb; 103(3):352-6. PubMed ID: 18778340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia.
    Chung JS; Seo WI; Oh CK; Kim SC; Park MC; Park SH; Yu J; Lee CH; Kim W; Park TY; Min KS; Chung JI
    Investig Clin Urol; 2020 Jan; 61(1):67-74. PubMed ID: 31942465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thulium laser (RevoLix) vaporesection versus vapoenucleation with morcellator (Piranha) for the treatment of benign prostatic obstruction: a propensity-matched multicenter analysis.
    Chung JS; Kang PM; Seo WI; Oh CK; Kim SC; Park SH; Choi JH; Yoon JH; Kang DI; Chung JI
    Int J Urol; 2014 Nov; 21(11):1156-61. PubMed ID: 25040293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro study on the vaporization ratio of 2-microm laser in human prostatic tissue.
    Yang Y; Sun D; Wei Z; Xu F; Hong B; Zhang X
    J Huazhong Univ Sci Technolog Med Sci; 2010 Apr; 30(2):198-200. PubMed ID: 20407873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up.
    Bach T; Herrmann TR; Ganzer R; Burchardt M; Gross AJ
    World J Urol; 2007 Jun; 25(3):257-62. PubMed ID: 17530258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An ex vivo study on the vaporization ratio of the prostatic tissue lased by the 2 micron laser].
    Sun DC; Wei ZT; Xu F; Xu Y; Yang Y; Hong BF; Zhang X
    Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(1):42-4. PubMed ID: 20302753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: ex-vivo and in-vivo investigations.
    Seitz M; Bayer T; Ruszat R; Tilki D; Bachmann A; Gratzke C; Schlenker B; Stief C; Sroka R; Reich O
    BJU Int; 2009 Mar; 103(6):770-5. PubMed ID: 18990158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 2-microm continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up.
    Fu WJ; Zhang X; Yang Y; Hong BF; Gao JP; Cai W; Zhang P; Wang XX
    Urology; 2010 Jan; 75(1):194-9. PubMed ID: 19819535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro investigation of wavelength-dependent tissue ablation: laser prostatectomy between 532 nm and 2.01 microm.
    Kang HW; Kim J; Peng YS
    Lasers Surg Med; 2010 Mar; 42(3):237-44. PubMed ID: 20333741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI assessment of tissue effects after 180-W XPS greenlight laser vaporization of the prostate.
    Huet R; Mathieu R; Rohou T; Peyronnet B; Manunta A; Verhoest G; Bensalah K; Vincendeau S
    Lasers Surg Med; 2017 Aug; 49(6):577-581. PubMed ID: 28401579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 70 vs 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation.
    Bach T; Huck N; Wezel F; Häcker A; Gross AJ; Michel MS
    BJU Int; 2010 Aug; 106(3):368-72. PubMed ID: 19912204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [5-year follow-up to transurethral vaporesection of the prostate using the 2 micron continuous wave laser for the treatment of benign prostatic hyperplasia].
    Xu Y; Sun DC; Yang Y; Wei ZT; Hong BF; Zhang X
    Zhonghua Wai Ke Za Zhi; 2013 Feb; 51(2):119-22. PubMed ID: 23711003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic vaporesection of the prostate using the continuous-wave 2-microm thulium laser: outcome and demonstration of the surgical technique.
    Szlauer R; Götschl R; Razmaria A; Paras L; Schmeller NT
    Eur Urol; 2009 Feb; 55(2):368-75. PubMed ID: 19022557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement.
    Seitz M; Ruszat R; Bayer T; Tilki D; Bachmann A; Stief C; Sroka R; Reich O
    Lasers Med Sci; 2009 May; 24(3):419-24. PubMed ID: 18685885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RevoLix 2 micron continuous wave laser vaporesection for the treatment of high-risk patients with benign prostatic hyperplasia.
    Si J; Gu B; Yu J; Xu Y
    Photomed Laser Surg; 2011 Feb; 29(2):105-7. PubMed ID: 21182453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thulium laser vaporesection versus transurethral electrovaporization of the prostate in high-risk patients with benign prostatic hyperplasia.
    Zhu Z; Shen Z; Tu F; Zhu Y; Sun F; Shao Y; Wang H; Zhong S; Xu C
    Photomed Laser Surg; 2012 Dec; 30(12):714-8. PubMed ID: 23113512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of the safety and efficacy of a high-power 450-nm semiconductor blue laser in the treatment of benign prostate hyperplasia.
    Xu X; Jiang D; Liu G; Mu L; Zeng J; Yang L; He D
    Lasers Med Sci; 2022 Feb; 37(1):555-561. PubMed ID: 33770281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.